Nurix Therapeutics, Inc. · NASDAQ:NRIX

Hansen Gwenn sold 4,356 Nurix Therapeutics, Inc. shares (Form 4)

Traded Aug 5, 2026 · Filed Aug 5, 2026

On Aug 5, 2026, Hansen Gwenn (Chief Scientific Officer) sold 4,356 Nurix Therapeutics, Inc. shares at US$25.00 for US$109K under a trading plan, leaving 117,227 shares. Filed Aug 5, 2026 (Form 4).

Sold
4,356 shares
Price
US$25.00
Value
US$109K
Holding after
117,227 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 5, 2026Common StockOption exercise4,356US$1.86121,583Direct
Aug 5, 2026Common StockSale4,356US$25.00117,227Direct

Source

View original at SEC

Related